Buprenorphine Sublingual Tablets (C-III)…

Date

Sept. 9, 2026

Risk class

Class III (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences)

Status

Ongoing

Filed by

American Health Packaging

Product

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Reason

Labeling: Label Mix-up

Distribution pattern

US Nationwide.

Quantity

10,953 cartons.

Codes and lots

Lot # 1030023, Exp Date: 06/30/2027.

Recall started

Aug. 19, 2026

Recall number

D-0840-2026

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0840-2026. The agency record governs; check it and the company before acting.